Welcome to our dedicated page for Prenetics news (Ticker: PRE), a resource for investors and traders seeking the latest updates and insights on Prenetics stock.
Prenetics Global Limited (NASDAQ: PRE) generates an active stream of company news centered on its evolution as a health sciences business and the rapid growth of its IM8 premium health and longevity brand. Press releases describe Prenetics as a leading health sciences company focused on redefining the future of health and longevity through IM8, a premium core nutrition platform co-founded with David Beckham and championed by World No. 1 and four-time Grand Slam winner Aryna Sabalenka.
News updates commonly highlight IM8’s growth milestones, including disclosures that the brand reached over $100 million in annualized recurring revenue within roughly 11 months of launch and has been characterized by the company as the fastest-growing supplement brand in industry history. Articles also cover monthly revenue achievements, subscription metrics, and international expansion, reflecting IM8’s role as the centerpiece of Prenetics’ strategy.
Investors following PRE can also expect news on capital allocation and financing activities. Recent announcements include a best efforts public offering of Class A ordinary shares with accompanying warrants, a voluntary warrant exchange program designed to reduce potential dilution and simplify the capital structure, and updates on the company’s Bitcoin treasury strategy. Prenetics has communicated a shift away from new Bitcoin purchases, choosing instead to maintain existing holdings as a treasury reserve while directing new capital exclusively toward IM8.
Another recurring theme in Prenetics news is strategic portfolio optimization. Releases describe the sale of ACT Genomics, the divestiture of Europa Sports Partners, and an ongoing review of other non-core assets such as CircleDNA and the company’s stake in Insighta. These items are presented as part of a broader effort to focus on IM8 and improve operating margins.
News items may also include earnings announcements, conference participation, and insider share purchases by members of the executive leadership team, which are furnished to the SEC on Form 6-K. For readers tracking PRE, this news page provides a consolidated view of operational updates, financial developments, capital structure changes, and strategic decisions affecting Prenetics and its IM8 brand.
Ellington Financial (NYSE: EFC) has announced the redemption of all 957,133 outstanding shares of its Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock. The redemption is scheduled for December 13, 2024, at $25.540558 per share, comprising the $25.00 liquidation preference plus $0.540558 in estimated accrued dividends. The Series E Preferred Stock will be suspended from NYSE trading before market open on the redemption date, and all shares will be redeemed through the Depository Trust Company (DTC).
Prenetics (NASDAQ: PRE) announced its participation in the upcoming Sidoti Virtual Micro Cap Conference scheduled for November 13-14, 2024. CEO Danny Yeung and CFO Stephen Lo will deliver a virtual presentation on November 13th at 8:30 a.m. ET. The presentation will be accessible through the company's investor relations website. Management will also be available for one-on-one meetings with investors on November 13th.
Prenetics Global (NASDAQ: PRE) announced a strategic US$30 million investment by Tencent in Insighta, valuing the early cancer detection company at US$200 million. This investment reduces Prenetics' stake in Insighta from 50% to 35%, while Insighta's co-founders retain their 50% shareholding. Prenetics receives US$30 million in cash from the sale of secondary shares to Tencent, boosting its pro forma cash and short-term assets to over US$90 million.
Insighta's early cancer detection platform uses proprietary FRAGMA technology, which detects DNA methylation aberrations in cell-free DNA. The company has begun clinical trials in Mainland China for liver cancer detection and plans to expand to lung cancer. With US$80 million in cash reserves, Insighta is well-funded to advance its clinical trials and commercialization efforts.
Prenetics Global (NASDAQ: PRE) has announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix, marking a significant expansion into the $187 billion US consumer health and wellness industry. This strategic move aligns with Prenetics' recent launch of IM8, a health and wellness brand co-founded with David Beckham. Key highlights include:
1. Europa is one of the largest sports nutrition distributors in the US, with a network of 10,000+ gyms.
2. The acquisition establishes Prenetics' US headquarters in Charlotte, NC.
3. Prenetics projects $100 million+ revenue in the consumer segment for FY2025.
4. Europa distributes over 120 brands and operates three warehouses with 200,000+ sq ft of space.
5. Hubmatrix, Europa's subsidiary, provides 3PL direct-to-consumer fulfillment for health and wellness brands.
Prenetics (NASDAQ: PRE), a pioneering health sciences company, has announced a strategic partnership with international footballer and entrepreneur David Beckham. Beckham has invested in Prenetics and co-founded a new health and wellness brand, IM8, along with the company. IM8 will focus on innovative consumer health products, with further details forthcoming.
Beckham highlighted his lifelong access to top medical professionals and his excitement to work with Prenetics, a company dedicated to scientific advancements in health. Prenetics CEO Danny Yeung emphasized the transformative nature of this partnership, noting Beckham’s alignment with the company’s values of discipline, teamwork, and health.
Beckham's involvement includes collaboration with Prenetics shareholder Professor Dennis Lo, known for his pioneering work in non-invasive prenatal testing and early cancer detection. The partnership aims to drive significant contributions to the consumer health and wellness industry.
For more information, interested parties can join the waitlist at IM8health.com and follow IM8 Health on Instagram.
Prenetics Global (NASDAQ: PRE) has announced the addition of Kathryn M. Henry and David Vanderveen to its Board of Directors. This strategic move comes as Prenetics prepares to expand into the consumer health and wellness sector. CEO Danny Yeung believes that the extensive expertise of Henry and Vanderveen in consumer and health sectors will significantly enhance shareholder value. Henry brings experience from her roles at Lululemon and Gap, particularly in global information and technology operations. Vanderveen, with a robust 30-year track record in the beverage, nutrition, and technology sectors, is expected to contribute significantly to Prenetics' ambitious goals. Both directors expressed enthusiasm about their new roles and the company's potential for market disruption.
Prenetics Global (NASDAQ: PRE) has released its unaudited financial results for Q1 2024. The company reported a 30.2% increase in revenue to $6.4 million and a 159.8% rise in gross profit to $3.8 million compared to Q1 2023. Adjusted EBITDA improved by 55.9%, amounting to a loss of $4.1 million. Prenetics holds cash and short-term assets totaling $86.6 million. Insighta, a joint venture focused on early cancer detection, also had a cash balance of $79.8 million.
The company is strategically pivoting towards the U.S. consumer healthcare market, establishing dual headquarters in the U.S. and focusing on science-based health solutions. Insighta is progressing with promising pre-clinical data on prostate cancer and is set to commence a 1,500-person clinical trial in July 2024.
Prenetics Global (NASDAQ: PRE), a genomic-driven health sciences company, has partnered with MZ Group to lead a strategic investor relations and financial communications program. This collaboration aims to increase the company's visibility and communicate its technological advancements in health and wellness. Prenetics offers services like health-focused DNA tests, early cancer detection, and genomic profiling for targeted cancer therapy. With a strong cash position, no debt, and a dedicated management team, Prenetics is poised for growth and value creation for its shareholders. MZ Group, known for its expertise and global presence, will provide strategic counsel to Prenetics, enhancing market connections and communication strategies.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Prenetics (PRE)?
What is the market cap of Prenetics (PRE)?
